Despite prevalence of chronic conditions associated with aortic stenosis in women over 65, the majority have never been referred to a cardiologist; Racial disparities may present further opportunities for awareness amongst women at risk for cardiovascular disease   DUBLIN, April 7, 2024 /PRNewswire/ -- Medtronic plc, a global leader in healthcare technology, today unveiled topline findings of its comprehensive survey on women's perceptions and knowledge of risk factors, treatment patterns, and preventive ca ...

The most recent trading session ended with Medtronic (MDT) standing at $83.92, reflecting a -1.27% shift from the previouse trading day's closing. This change lagged the S&P 500's daily loss of 1.23%. Meanwhile, the Dow experienced a drop of 1.36%, and the technology-dominated Nasdaq saw a decrease of 1.4%.Heading into today, shares of the medical device company had lost 0.64% over the past month, outpacing the Medical sector's loss of 1.23% and lagging the S&P 500's gain of 1.61% in that time.The investmen ...

Medtronic plc (MDT) recently secured the FDA’s approval for the Evolut FX+ transcatheter aortic valve replacement (TAVR) system for the treatment of symptomatic severe aortic stenosis. The latest Evolut FX+ TAVR system maintains the valve performance benefits of the legacy Evolut TAVR platform and is designed to facilitate coronary access.The latest development will significantly boost the Coronary & Renal Denervation and Structural Heart & Aortic businesses, which are part of Medtronic’s Cardiovascular por ...

If you're an everyday investor looking for stocks that can deliver steadily rising dividend payouts over long periods, the healthcare sector is the right place to begin your search. People get sick during economic downturns just as often as they do when businesses are booming.Medtronic (MDT 0.27%) and Walgreens Boots Alliance (WBA 3.19%) are two dividend-paying giants of the healthcare sector. Both offer yields that are far more attractive than the paltry 1.4% yield you can receive from the average stock in ...

When you think of artificial intelligence (AI), you probably think of the technology companies creating the nuts and bolts that help AI come to life -- such as Nvidia's chips or Super Micro Computer's servers. We've already seen growth in these companies' earnings thanks to sales of their products to customers developing AI projects. They and some of their peers continue to make great investments because growth in the AI market looks like it's just getting started.But there's another way to invest in AI, an ...

Medtronic moves for patent infringement litigation to resume DUBLIN, March 21, 2024  /PRNewswire/ -- Medtronic (NYSE:MDT), the global leader in healthcare technology, today announced that the Patent Trial and Appeal Board (PTAB) of the U.S. Patent and Trademark Office has affirmed the validity of claims in two of its patents in an ongoing patent infringement lawsuit filed by Medtronic against Axonics over sacral neuromodulation (SNM) technologies. Cumulatively, the PTAB has now upheld the validity of five o ...

Investors are enjoying the ongoing bull run. The S&P 500 and Nasdaq Composite recently hit all-time highs. Though that's pretty exciting, bull markets don't last forever. Equities that can perform well in good times are great. Those that can perform well over the long run, through bull and bear markets, economic peaks and lows, are even better.Let's look at two excellent stocks that ought to deliver solid returns well beyond the current bull market: Medtronic (MDT 0.31%) and Merck (MRK -0.03%).1. MedtronicM ...

“Higher for longer” may prove true as sticky inflation indicates the higher-rate environment might be here to stay. As interest rates stay steady, risk-averse investors gravitate towards short-term Treasuries for safety. However, a handful of stocks for high-interest rates are stepping into the limelight for those seeking a blend of excitement and potential upside. Dividend-paying and high-yield stocks present an attractive mix of predictable income and the thrill of market dynamics without compromising the ...

New pharmacokinetic data demonstrate Virtue® SAB enables extended release of sirolimus above required tissue concentrations in target arterial sites without polymer degradation or detectable remaining polymer within 90 days of balloon deliveryAVIM therapy presentation highlighted recent clinical results showing favorable hemodynamic effects and long-term reduction in 24-hour ambulatory systolic blood pressure, as well as the design of the BACKBEAT global pivotal study now enrolling in collaboration with Med ...

Medtronic plc (NYSE:MDT) 2024 Barclays 26th Annual Healthcare Conference Call March 12, 2024 8:00 AM ET Company Participants Karen Parkhill - CFO Conference Call Participants Matt Miksic - Barclays Matt Miksic Good morning. Thanks so much for joining us. My name is Matt Miksic, I’m US Medical Device Analyst here at Barclays, and we are very pleased to have with us today Medtronic, specifically, CFO, Karen Parkhill, so thanks again so much for joining us. Karen Parkhill Thank you, Matt. Great to be here. Mat ...